|
1
|
Saijo K and Glass CK: Microglial cell
origin and phenotypes in health and disease. Nat Rev Immunol.
11:775–787. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iadecola C and Anrather J: The immunology
of stroke: From mechanisms to translation. Nat Med. 17:796–808.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lawrence T and Natoli G: Transcriptional
regulation of macrophage polarization: Enabling diversity with
identity. Nat Rev Immunol. 11:750–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sehgal N, Agarwal V, Valli RK, Joshi SD,
Antonovic L, Strobel HW and Ravindranath V: Cytochrome P4504f, a
potential therapeutic target limiting neuroinflammation. Biochem
Pharmacol. 82:53–64. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Firdous AP, Kuttan G and Kuttan R:
Anti-inflammatory potential of carotenoid meso-zeaxanthin and its
mode of action. Pharm Biol. 53:961–967. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abate W, Alghaithy AA, Parton J, Jones KP
and Jackson SK: Surfactant lipids regulate LPS-induced
interleukin-8 production in A549 lung epithelial cells by
inhibiting translocation of TLR4 into lipid raft domains. J Lipid
Res. 51:334–344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dai XJ, Li N, Yu L, Chen ZY, Hua R, Qin X
and Zhang YM: Activation of BV2 microglia by lipopolysaccharide
triggers an inflammatory reaction in PC12 cell apoptosis through a
toll-like receptor 4-dependent pathway. Cell Stress Chaperones.
20:321–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakahata N: Thromboxane A2:
Physiology/pathophysiology, cellular signal transduction and
pharmacology. Pharmacol Ther. 118:18–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitanaka J, Hashimoto H, Sugimoto Y,
Sawada M, Negishi M, Suzumura A, Marunouchi T, Ichikawa A and Baba
A: cDNA cloning of a thromboxane A2 receptor from rat astrocytes.
Biochim Biophys Acta. 1265:220–223. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blackman SC, Dawson G, Antonakis K and Le
Breton GC: The identification and characterization of
oligodendrocyte thromboxane A2 receptors. J Biol Chem. 273:475–483.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakahata N, Miyamoto A, Ohkubo S, Ishimoto
H, Sakai K, Nakanishi H, Ohshika H and Ohizumi Y: Gq/11
communicates with thromboxane A2 receptors in human astrocytoma
cells, rabbit astrocytes and human platelets. Res Commun Mol Pathol
Pharmacol. 87:243–251. 1995.PubMed/NCBI
|
|
12
|
Obara Y, Kurose H and Nakahata N:
Thromboxane A2 promotes interleukin-6 biosynthesis mediated by an
activation of cyclic AMP-response element-binding protein in 1321N1
human astrocytoma cells. Mol Pharmacol. 68:670–679. 2005.PubMed/NCBI
|
|
13
|
Yang W, Yan A, Zhang T, Shao J, Liu T,
Yang X, Xia W and Fu Y: Thromboxane A2 receptor stimulation
enhances microglial interleukin-1b and NO biosynthesis mediated by
the activation of ERK pathway. Front Aging Neurosci. 8:82016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ogletree ML, Harris DN, Greenberg R,
Haslanger MF and Nakane M: Pharmacological actions of SQ 29,548, a
novel selective thromboxane antagonist. J Pharmacol Exp Ther.
234:435–441. 1985.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Boje KM: Nitric oxide neurotoxicity in
neurodegenerative diseases. Front Biosci. 9:763–776. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kacimi R, Giffard RG and Yenari MA:
Endotoxin-activated microglia injure brain derived endothelial
cells via NF-kB, JAK-STAT and JNK stress kinase pathways. J Inflamm
(Lond). 8:72011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Min S, More SV, Park JY, Jeon SB, Park SY,
Park EJ, Yoon SH and Choi DK: EOP, a newly synthesized ethyl
pyruvate derivative, attenuates the production of inflammatory
mediators via p38, ERK and NF-kappaB pathways in
lipopolysaccharide-activated BV-2 microglial cells. Molecules.
19:19361–19375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kreutzberg GW: Microglia: A sensor for
pathological events in the CNS. Trends Neurosci. 19:312–318. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Le W, Rowe D, Xie W, Ortiz I, He Y and
Appel SH: Microglial activation and dopaminergic cell injury: An in
vitro model relevant to Parkinson's disease. J Neurosci.
21:8447–8455. 2001.PubMed/NCBI
|
|
21
|
Yu Z, Tang L, Chen L, Li J, Wu W and Hu C:
Capillarisin suppresses lipopolysaccharide-induced inflammatory
mediators in BV2 microglial cells by suppressing TLR4-mediated
NF-kappa B and MAPKs signaling pathway. Neurochem Res.
40:1095–1101. 2015. View Article : Google Scholar : PubMed/NCBI
|
